Net profit of Eiko Lifesciences rose 290.48% to Rs 0.82 crore in the quarter ended September 2025 as against Rs 0.21 crore during the previous quarter ended September 2024. Sales rose 18.86% to Rs 9.20 crore in the quarter ended September 2025 as against Rs 7.74 crore during the previous quarter ended September 2024. ParticularsQuarter EndedSep. 2025Sep. 2024% Var. Sales9.207.74 19 OPM %7.934.65 - PBDT1.220.45 171 PBT1.070.29 269 NP0.820.21 290 Powered by Capital Market - Live News

Eiko Lifesciences will hold a meeting of the Board of Directors of the Company on 31 October 2025.Powered by Capital Market - Live News

Eiko Lifesciences announced that the 48th Annual General Meeting(AGM) of the company will be held on 5 September 2025.Powered by Capital Market - Live News

Net profit of Eiko Lifesciences rose 97.14% to Rs 0.69 crore in the quarter ended June 2025 as against Rs 0.35 crore during the previous quarter ended June 2024. Sales declined 30.70% to Rs 7.45 crore in the quarter ended June 2025 as against Rs 10.75 crore during the previous quarter ended June 2024. ParticularsQuarter EndedJun. 2025Jun. 2024% Var. Sales7.4510.75 -31 OPM %7.113.81 - PBDT1.060.64 66 PBT0.910.47 94 NP0.690.35 97 Powered by Capital Market - Live News

Eiko Lifesciences will hold a meeting of the Board of Directors of the Company on 29 July 2025.Powered by Capital Market - Live News